PF-10042

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePF-10042

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLeukotriene B4 receptor antagonists

TargetsLeukotriene B4 receptor

Therapy Area/IndicationsAllergic asthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPurdue Frederick

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPurdue Frederick

Active IndicationsN/A

Inactive IndicationsAllergic asthma

ATC CodeN/A